Found 14 matching trials
Autologous CARTmeso/19 Against Pancreatic Cancer EARLY_PHASE1 Pancreatic cancer patients receive chimeric antigen receptor (CAR) T cells ...
Show More Location
First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy N/A The purpose of this study is to learn about possible changes in cognitive (...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL PHASE2 This is a single center, single arm, open-label phase 2 study to determine ...
Show More Location
University of Pennsylvania
Learn More & Join Trial
Study of CAR-T Therapy in Older Patients N/A This study is being done to find out how older patients respond to CAR-T ce...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia. PHASE1 This is a single center, open-label ,phase 1/2 study to evaluate the safety...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma PHASE1 Placing a tumor antigen chimeric receptor that has been created in the labo...
Show More Location
First Affiliated Hospital, Soochow University
Learn More & Join Trial
Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL) EARLY_PHASE1 Open-label pilot study to determine safety and efficacy of CART-19 cells in...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies PHASE1 The purposed of this study is to determine whether an infusion with special...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome PHASE1 This is a two cohort, open-label, pilot study to describe the efficacy of a...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas PHASE1 This is a non-randomized clinical trial to evaluate the safety and efficacy...
Show More Location
Stanford University
Learn More & Join Trial